March 26, 2020 / 12:59 AM / in 11 days

BRIEF-Intervacc Awarded Funding From Vinnova For Further Development Of Vaccine Against Staphylococcus Aureus Infections

March 25 (Reuters) - Intervacc AB:

* INTERVACC AWARDED FUNDING FROM VINNOVA FOR FURTHER DEVELOPMENT OF VACCINE AGAINST STAPHYLOCOCCUS AUREUS INFECTIONS

* PROJECT WILL BE CO-FINANCED BY CO AND VINNOVA

* FINANCING COVERS A PART OF PRECLINICAL PHASE OF DEVELOPMENT PROGRAM WITH A BUDGET OF SEK 3.9 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below